Skip to main content

Table 2 Log-rank test for the expression levels of 11 miRNAs in peripheral blood

From: Prognostic value of plasma microRNAs for non-small cell lung cancer based on data mining models

Variables

Cut-off values

expression groups

Cases

Overall Survival (months)a

χ2

P

miRNA-16

1.79

Low expression

40

38.00 (18.50, 57.00)

2.111

0.146

High expression

29

16.00 (9.50, 53.50)

miRNA-21

0.83

Low expression

22

25.50 (15.25, 55.25)

0.602

0.438

High expression

47

38.00 (14.00, 58.00)

miRNA-20a

7.18

Low expression

57

35.00 (15.50, 56.00)

3.135

0.077

High expression

12

15.50 (6.25, 46.75)

miRNA-210

4.09

Low expression

61

38.00 (15.00, 56.50)

7.224

0.007

High expression

8

19.00 (7.25, 25.75)

miRNA-145

1.08

Low expression

34

22.00 (12.75, 55.25)

2.180

0.140

High expression

35

42.00 (15.00, 59.00)

miRNA-126

0.94

Low expression

21

30.00 (15.50, 53.00)

0.771

0.380

High expression

48

33.00(13.25,56.00)

miRNA-223

4.04

Low expression

50

36.50 (15.75,56.00)

2.864

0.091

High expression

19

17.00 (6.00,57.00)

miRNA-197

0.78

Low expression

26

51.50 (21.00,57.00)

4.853

0.028

High expression

43

18.00 (11.00,53.00)

miRNA-30a

1.03

Low expression

41

23.00 (12.50,52.00)

4.414

0.036

High expression

28

53.00 (15.25,59.75)

miRNA-30d

1.12

Low expression

30

21.00 (11.00,56.00)

1.548

0.213

High expression

39

42.00 (15.00,59.00)

miRNA-25

0.58

Low expression

14

20.50 (14.75,40.00)

1.461

0.227

High expression

55

38.00 (14.00,56.00)

  1. aOverall survival was expressed by T50 (T75, T25)